Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
11.85 NOK | -0.03% |
|
+12.71% | -57.39% |
05-29 | BerGenBio ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-29 | Transcript : BerGenBio ASA, Q1 2024 Earnings Call, May 29, 2024 |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
43.42M | - | - | ||||
122B | ||||||
113B | ||||||
26.49B | - | |||||
19.4B | - | |||||
16.24B |
- Stock Market
- Equities
- BGBIO Stock
- Charts BerGenBio ASA
- Sector Chart